Papadopoulou, E.; Vardas, E.; Tziveleka, S.; Georgaki, M.; Kouri, M.; Katoumas, K.; Piperi, E.; Nikitakis, N.G.
Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases. Dent. J. 2022, 10, 232.
https://doi.org/10.3390/dj10120232
AMA Style
Papadopoulou E, Vardas E, Tziveleka S, Georgaki M, Kouri M, Katoumas K, Piperi E, Nikitakis NG.
Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases. Dentistry Journal. 2022; 10(12):232.
https://doi.org/10.3390/dj10120232
Chicago/Turabian Style
Papadopoulou, Erofili, Emmanouil Vardas, Styliani Tziveleka, Maria Georgaki, Maria Kouri, Konstantinos Katoumas, Evangelia Piperi, and Nikolaos G. Nikitakis.
2022. "Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases" Dentistry Journal 10, no. 12: 232.
https://doi.org/10.3390/dj10120232
APA Style
Papadopoulou, E., Vardas, E., Tziveleka, S., Georgaki, M., Kouri, M., Katoumas, K., Piperi, E., & Nikitakis, N. G.
(2022). Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases. Dentistry Journal, 10(12), 232.
https://doi.org/10.3390/dj10120232
